Showing 201 - 220 results of 516 for search '"Cell therapy"', query time: 0.08s Refine Results
  1. 201
  2. 202

    Neuronal Differentiation of Adipose Derived Stem Cells: Progress So Far by T. J. Moore, Heidi Abrahamse

    Published 2014-01-01
    “…However, none of these strategies have yet been able to produce a fully functional descendent suitable for use in stem cell therapy. Due to the positive effects that low level laser irradiation has shown in stem cell studies to date, we propose that it could enhance the processes involved in the differentiation of adipose derived stem cells into neuronal lineages.…”
    Get full text
    Article
  3. 203

    Unveiling causal immune cell–gene associations in multiple myeloma: insights from systematic reviews and Mendelian randomization analyses by Hui Zhang, Hui Zhang, Ling Zhang, Jing-Xuan Lian, Zhi-Fu Kou, Yu Zhu, Yu Zhu, Li-Tian Ma, Li-Tian Ma, Jin Zheng, Jin Zheng, Can-Jun Zhao, Can-Jun Zhao

    Published 2025-01-01
    “…BCMA, CD38, and GPRC5D CAR-T-cell therapies had superior response rates, whereas BCMA and CD3 CAR-T-cell therapy rates lagged at 61.8%. …”
    Get full text
    Article
  4. 204

    Metformin Ameliorates D-Galactose-Induced Senescent Human Bone Marrow-Derived Mesenchymal Stem Cells by Enhancing Autophagy by Pingting Ye, Lei Feng, Dan Zhang, Ruihao Li, Yixuan Wen, Xiaohan Tong, Shuo Shi, Chunyan Dong

    Published 2023-01-01
    “…Human bone marrow-derived mesenchymal stem cells (hBMSCs) are promising candidates for stem cell therapy in clinical trials. Applications of hBMSCs in clinical therapy are limited by cellular senescence due to long-term ex vivo expansion. …”
    Get full text
    Article
  5. 205
  6. 206
  7. 207
  8. 208
  9. 209
  10. 210
  11. 211

    Understanding and Prevention of “Therapy-” Induced Dyskinesias by Iciar Aviles-Olmos, Zinovia Kefalopoulou, Thomas Foltynie

    Published 2012-01-01
    “…However, the spectre of dyskinesia in the absence of L-dopa, the so-called “off-phase” or graft-induced dyskinesia (GID), remains a major obstacle particularly in the further development of cell therapy in PD, but it is also a concern for proponents of gene therapy approaches. …”
    Get full text
    Article
  12. 212

    Current Therapeutic Strategies for Stem Cell-Based Cartilage Regeneration by Yoojun Nam, Yeri Alice Rim, Jennifer Lee, Ji Hyeon Ju

    Published 2018-01-01
    “…Specifically, this review compares a surgical regenerative technique (microfracture) and cell therapy, cell therapy with and without a scaffold, and therapy with nonaggregated and aggregated cells. …”
    Get full text
    Article
  13. 213

    Direct Control of Stem Cell Behavior Using Biomaterials and Genetic Factors by Jeong-Kee Yoon, Mi-Lan Kang, Joo Hyun Park, Kyoung-Mi Lee, Young Min Shin, Jin Woo Lee, Hyun Ok Kim, Hak-Joon Sung

    Published 2018-01-01
    “…Stem cells have recently emerged as an important candidate for cell therapy. However, some major limitations still exist such as a small quantity of cell supply, senescence, and insufficient differentiation efficiency. …”
    Get full text
    Article
  14. 214
  15. 215
  16. 216
  17. 217

    Pivotal Cytoprotective Mediators and Promising Therapeutic Strategies for Endothelial Progenitor Cell-Based Cardiovascular Regeneration by Hyunyun Kim, Sujin Kim, Sang Hong Baek, Sang-Mo Kwon

    Published 2016-01-01
    “…Cardiovascular diseases (CVDs), including atherosclerosis, stroke, and myocardial infarction, is a major cause of death worldwide. In aspects of cell therapy against CVD, it is generally accepted that endothelial progenitor cells (EPCs) are potent neovascular modulators in ischemic tissues. …”
    Get full text
    Article
  18. 218

    Innovative approaches to boost mesenchymal stem cells efficacy in myocardial infarction therapy by Chuanfeng An, Yuan Zhao, Lipeng Guo, Zhijian Zhang, Chunxiao Yan, Shiying Zhang, Yujie Zhang, Fei Shao, Yuanyuan Qi, Xun wang, Huanan Wang, Lijun Zhang

    Published 2025-04-01
    “…The ongoing research and technological advancements continue to push the boundaries, hoping to make stem cell therapy a mainstream treatment for heart disease.…”
    Get full text
    Article
  19. 219
  20. 220

    Injectable Tumoricidal Neural Stem Cell-Laden Hydrogel for Treatment of Glioblastoma Multiforme—An In Vivo Safety, Persistence, and Efficacy Study by Jasmine L. King, Alain Valdivia, Shawn D. Hingtgen, S. Rahima Benhabbour

    Published 2024-12-01
    “…Induced neural stem cell (iNSC) therapy is a promising, personalized cell therapy approach that has been explored to circumvent challenges associated with the current GBM treatment. …”
    Get full text
    Article